Abstract

N-α-acetyltransferase D (NatD) mediates N-α-terminal acetylation (Nt-acetylation) of histone H4 known to be involved in cell growth. Here we report that NatD promotes the migratory and invasive capabilities of lung cancer cells in vitro and in vivo. Depletion of NatD suppresses the epithelial-to-mesenchymal transition (EMT) of lung cancer cells by directly repressing the expression of transcription factor Slug, a key regulator of EMT. We found that Nt-acetylation of histone H4 antagonizes histone H4 serine 1 phosphorylation (H4S1ph), and that downregulation of Nt-acetylation of histone H4 facilitates CK2α binding to histone H4 in lung cancer cells, resulting in increased H4S1ph and epigenetic reprogramming to suppress Slug transcription to inhibit EMT. Importantly, NatD is commonly upregulated in primary human lung cancer tissues where its expression level correlates with Slug expression, enhanced invasiveness, and poor clinical outcomes. These findings indicate that NatD is a crucial epigenetic modulator of cell invasion during lung cancer progression.

Details

Title
NatD promotes lung cancer progression by preventing histone H4 serine phosphorylation to activate Slug expression
Author
Ju, Junyi 1   VIAFID ORCID Logo  ; Chen, Aiping 2 ; Deng, Yexuan 1 ; Liu, Ming 1 ; Wang, Ying 1 ; Wang, Yadong 1 ; Nie, Min 1 ; Wang, Chao 3 ; Ding, Hong 4 ; Yao, Bing 1 ; Gui, Tao 1 ; Li, Xinyu 1 ; Xu, Zhen 5 ; Ma, Chi 1 ; Song, Yong 2 ; Kvansakul, Marc 6   VIAFID ORCID Logo  ; Zen, Ke 1 ; Chen-Yu, Zhang 1 ; Luo, Cheng 4   VIAFID ORCID Logo  ; Fang, Ming 3 ; Huang, David C S 5 ; Allis, C David 7 ; Tan, Renxiang 8 ; Zeng, Changjiang Kathy 9 ; Wei, Jiwu 2 ; Zhao, Quan 1 

 The State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China 
 Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China 
 Institute of Life Sciences, Southeast University, Nanjing, China 
 Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China 
 Department of Medical Biology, The Walter and Eliza Hall Institute of Medical Research, University of Melbourne, Melbourne, VIC, Australia 
 Department of Biochemistry, La Trobe University, Melbourne, VIC, Australia 
 Laboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, NY, USA 
 The State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China; State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine, Nanjing, China 
 SQJ Biotechnologies Limited, Palo Alto, CA, USA 
Pages
1-14
Publication year
2017
Publication date
Oct 2017
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
1950622916
Copyright
© 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.